As GLP-1 weight-loss drug costs surge, most Connecticut employers cover them but impose conditions like prior authorization and lifestyle requirements to manage expenses, a strategy the state employee plan has used to slow spending growth
Their value is tendon, ligament, cartilage, and joint support during training
Research indicates that it enhances production of melatonin, contributing to the regulation of melatonin levelsa key factor in maintaining healthy circadian rhythms and deep sleep
Glucagon-Like Peptide 1 (GLP-1) Agonists Market Regional Analysis North America dominated the Glucagon-Like Peptide 1 (GLP-1) Agonists market and accounted for the largest revenue share of 41.38% in 2025 , supported by the high prevalence of type 2 diabetes and obesity, strong adoption of innovative GLP-1 receptor agonist therapies, and the presence of leading pharmaceutical manufacturers
Guide to infection prevention for outpatient settings: minimum expectations for safe care